Co-development and testing of an extended community pharmacy model of service delivery for managing osteoarthritis: protocol for a sequential, multi-methods study (PharmOA)

Medientyp: E-Artikel
Titel: Co-development and testing of an extended community pharmacy model of service delivery for managing osteoarthritis: protocol for a sequential, multi-methods study (PharmOA)
Beteiligte: Babatunde, Opeyemi O.; Cottrell, Elizabeth; White, Simon; Chudyk, Adrian; Healey, Emma L.; Edwards, John; Nicholls, Elaine; O’Brien, Nicola; Todd, Adam; Walker, Christine; Stanford, Colin; Cork, Tania; Long, Angela; Simkins, Joanna; Mallen, Christian D.; Dziedzic, Krysia; Holden, Melanie A.
Erschienen: Springer Science and Business Media LLC, 2024
Erschienen in: BMC Musculoskeletal Disorders
Sprache: Englisch
DOI: 10.1186/s12891-023-07105-2
ISSN: 1471-2474
Schlagwörter: Orthopedics and Sports Medicine ; Rheumatology
Entstehung:
Anmerkungen:
Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Osteoarthritis is a common, painful and disabling long-term condition. Delivery of high-quality guideline-informed osteoarthritis care that successfully promotes and maintains supported self-management is imperative. However, osteoarthritis care remains inconsistent, including under use of core non-pharmacological approaches of education, exercise and weight loss.</jats:p> <jats:p>Community pharmacies are an accessible healthcare provider. United Kingdom government initiatives are promoting their involvement in a range of long-term conditions, including musculoskeletal conditions. It is not known what an enhanced community pharmacy role for osteoarthritis care should include, what support is needed to deliver such a role, and whether it would be feasible and acceptable to community pharmacy teams. In this (PharmOA) study, we aim to address these gaps, and co-design and test an evidence-based extended community pharmacy model of service delivery for managing osteoarthritis.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Informed by the Theoretical Domains Framework, Normalisation Process Theory, and the Medical Research Council (MRC) framework for developing complex interventions, we will undertake a multi-methods study involving five phases:</jats:p> <jats:p>1. Systematic review to summarise currently available evidence on community pharmacy roles in supporting adults with osteoarthritis and other chronic (non-cancer) pain.</jats:p> <jats:p>2. Cross-sectional surveys and one-to-one qualitative interviews with patients, healthcare professionals and pharmacy staff to explore experiences of current, and potential extended community pharmacy roles, in delivering osteoarthritis care.</jats:p> <jats:p>3. Stakeholder co-design to: a) agree on the extended role of community pharmacies in osteoarthritis care; b) develop a model of osteoarthritis care within which the extended roles could be delivered (PharmOA model of service delivery); and c) refine existing tools to support community pharmacies to deliver extended osteoarthritis care roles (PharmOA tools).</jats:p> <jats:p>4. Feasibility study to explore the acceptability and feasibility of the PharmOA model of service delivery and PharmOA tools to community pharmacy teams.</jats:p> <jats:p>5. Final stakeholder workshop to: a) finalise the PharmOA model of service delivery and PharmOA tools, and b) if applicable, prioritise recommendations for its wider future implementation.</jats:p> </jats:sec><jats:sec> <jats:title>Discussion</jats:title> <jats:p>This novel study paves the way to improving access to and availability of high-quality guideline-informed, consistent care for people with osteoarthritis from within community pharmacies.</jats:p> </jats:sec>
Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: